The main purpose of the Responsibility in Drug Advertising Act of 2025 is to regulate how pharmaceutical companies can advertise their drugs directly to consumers. The goal is to protect public health by ensuring that consumers are not exposed to potentially misleading or harmful information about newly approved medications. Key provisions of the Act include a three-year restriction on direct-to-consumer advertising for drugs approved by the Food and Drug Administration (FDA). This means that once a drug is approved, it cannot be advertised directly to consumers for the first three years.